Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Ask Questions (ASQ):Implementation of a Communication Intervention
NCT05025748 · View on ClinicalTrials.gov ↗
Study Summary
This clinical trial implements a communication intervention to improve patient-oncologist communication in the outpatient medical oncology setting. A communication brochure called the ASQ brochure may help patients prepare for the doctor visit by thinking through the questions that patients and patients' family want to ask the doctor.
Conditions Studied
Interventions
- BEHAVIORAL Behavioral Intervention
Study Locations (8)
Michigan
- Karmanos Cancer Institute at McLaren Bay Region — Bay City
- Karmanos Cancer Institute at McLaren Clarkston — Clarkston
- Karmanos Cancer Institute — Detroit
- Karmanos Cancer Institute at McLaren Flint — Flint
- Karmanos Cancer Institute at McLaren Macomb — Mount Clemens
- Karmanos Cancer Institute at McLaren Central Michigan — Mount Pleasant
- Karmanos Cancer Institute at McLaren Northern Michigan — Petoskey
- Karmanos Cancer Institute at McLaren Port Huron — Port Huron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2021-08-25 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05025748
The ClinicalTrials.gov registry entry for NCT05025748 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 97 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 10 conditions, with Stage IV Breast Cancer appearing as the primary indexed condition, and to 1 intervention — of which Behavioral Intervention is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05025748 reports 8 study locations spanning 1 distinct geographic area — top geographies include Michigan. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05025748 about?
NCT05025748 is a clinical study titled "Ask Questions (ASQ):Implementation of a Communication Intervention". This clinical trial implements a communication intervention to improve patient-oncologist communication in the outpatient medical oncology setting. A communication brochure called the ASQ brochure may help patients prepare for the doctor visit by thinking through the questions that patients and pati...
What is the current status of trial NCT05025748?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2021-08-25. Estimated completion is 2022-08-31.
What conditions does trial NCT05025748 study?
This clinical trial studies the following conditions: Stage IV Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer, Stage IV Lung Cancer, Stage II Prostate Cancer. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05025748?
The interventions under investigation include: Behavioral Intervention (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05025748?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 97 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05025748 being conducted?
This trial has 8 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.